1 Introduction to Research & Analysis Reports
1.1 Mercaptopurine Oral Solution Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mercaptopurine Oral Solution Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mercaptopurine Oral Solution Drugs Overall Market Size
2.1 Global Mercaptopurine Oral Solution Drugs Market Size: 2022 VS 2029
2.2 Global Mercaptopurine Oral Solution Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Mercaptopurine Oral Solution Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Mercaptopurine Oral Solution Drugs Players in Global Market
3.2 Top Global Mercaptopurine Oral Solution Drugs Companies Ranked by Revenue
3.3 Global Mercaptopurine Oral Solution Drugs Revenue by Companies
3.4 Global Mercaptopurine Oral Solution Drugs Sales by Companies
3.5 Global Mercaptopurine Oral Solution Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Mercaptopurine Oral Solution Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Mercaptopurine Oral Solution Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mercaptopurine Oral Solution Drugs Players in Global Market
3.8.1 List of Global Tier 1 Mercaptopurine Oral Solution Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Mercaptopurine Oral Solution Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Mercaptopurine Oral Solution Drugs Market Size Markets, 2022 & 2029
4.1.2 20mg/ml
4.1.3 5mg/ml
4.2 By Type – Global Mercaptopurine Oral Solution Drugs Revenue & Forecasts
4.2.1 By Type – Global Mercaptopurine Oral Solution Drugs Revenue, 2018-2023
4.2.2 By Type – Global Mercaptopurine Oral Solution Drugs Revenue, 2024-2029
4.2.3 By Type – Global Mercaptopurine Oral Solution Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Mercaptopurine Oral Solution Drugs Sales & Forecasts
4.3.1 By Type – Global Mercaptopurine Oral Solution Drugs Sales, 2018-2023
4.3.2 By Type – Global Mercaptopurine Oral Solution Drugs Sales, 2024-2029
4.3.3 By Type – Global Mercaptopurine Oral Solution Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Mercaptopurine Oral Solution Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mercaptopurine Oral Solution Drugs Market Size, 2022 & 2029
5.1.2 Hosptial
5.1.3 Pharmacy
5.2 By Application – Global Mercaptopurine Oral Solution Drugs Revenue & Forecasts
5.2.1 By Application – Global Mercaptopurine Oral Solution Drugs Revenue, 2018-2023
5.2.2 By Application – Global Mercaptopurine Oral Solution Drugs Revenue, 2024-2029
5.2.3 By Application – Global Mercaptopurine Oral Solution Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Mercaptopurine Oral Solution Drugs Sales & Forecasts
5.3.1 By Application – Global Mercaptopurine Oral Solution Drugs Sales, 2018-2023
5.3.2 By Application – Global Mercaptopurine Oral Solution Drugs Sales, 2024-2029
5.3.3 By Application – Global Mercaptopurine Oral Solution Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Mercaptopurine Oral Solution Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Mercaptopurine Oral Solution Drugs Market Size, 2022 & 2029
6.2 By Region – Global Mercaptopurine Oral Solution Drugs Revenue & Forecasts
6.2.1 By Region – Global Mercaptopurine Oral Solution Drugs Revenue, 2018-2023
6.2.2 By Region – Global Mercaptopurine Oral Solution Drugs Revenue, 2024-2029
6.2.3 By Region – Global Mercaptopurine Oral Solution Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Mercaptopurine Oral Solution Drugs Sales & Forecasts
6.3.1 By Region – Global Mercaptopurine Oral Solution Drugs Sales, 2018-2023
6.3.2 By Region – Global Mercaptopurine Oral Solution Drugs Sales, 2024-2029
6.3.3 By Region – Global Mercaptopurine Oral Solution Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Mercaptopurine Oral Solution Drugs Revenue, 2018-2029
6.4.2 By Country – North America Mercaptopurine Oral Solution Drugs Sales, 2018-2029
6.4.3 US Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.4.4 Canada Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.4.5 Mexico Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Mercaptopurine Oral Solution Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Mercaptopurine Oral Solution Drugs Sales, 2018-2029
6.5.3 Germany Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5.4 France Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5.5 U.K. Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5.6 Italy Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5.7 Russia Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.5.9 Benelux Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Mercaptopurine Oral Solution Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Mercaptopurine Oral Solution Drugs Sales, 2018-2029
6.6.3 China Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.6.4 Japan Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.6.5 South Korea Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.6.7 India Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Mercaptopurine Oral Solution Drugs Revenue, 2018-2029
6.7.2 By Country – South America Mercaptopurine Oral Solution Drugs Sales, 2018-2029
6.7.3 Brazil Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.7.4 Argentina Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Mercaptopurine Oral Solution Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Mercaptopurine Oral Solution Drugs Sales, 2018-2029
6.8.3 Turkey Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.8.4 Israel Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
6.8.6 UAE Mercaptopurine Oral Solution Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Nova Laboratories
7.1.1 Nova Laboratories Company Summary
7.1.2 Nova Laboratories Business Overview
7.1.3 Nova Laboratories Mercaptopurine Oral Solution Drugs Major Product Offerings
7.1.4 Nova Laboratories Mercaptopurine Oral Solution Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Nova Laboratories Key News & Latest Developments
8 Global Mercaptopurine Oral Solution Drugs Production Capacity, Analysis
8.1 Global Mercaptopurine Oral Solution Drugs Production Capacity, 2018-2029
8.2 Mercaptopurine Oral Solution Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Mercaptopurine Oral Solution Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mercaptopurine Oral Solution Drugs Supply Chain Analysis
10.1 Mercaptopurine Oral Solution Drugs Industry Value Chain
10.2 Mercaptopurine Oral Solution Drugs Upstream Market
10.3 Mercaptopurine Oral Solution Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mercaptopurine Oral Solution Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のメルカプトプリン経口液剤市場予測2023-2029:20mg/ml、5mg/ml |
【英語タイトル】Mercaptopurine Oral Solution Drugs Market, Global Outlook and Forecast 2023-2029 | |
・商品コード:MMG23JU5760 ・発行会社(調査会社):Market Monitor Global ・発行日:2023年6月 ・ページ数:70 ・レポート言語:英語 ・レポート形式:PDF ・納品方法:Eメール(受注後2-3営業日) ・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野:医薬品&医療 |
Single User(1名様閲覧用) | USD3,250 ⇒換算¥494,000 | 見積依頼/購入/質問フォーム |
Multi User(20名様閲覧用) | USD4,225 ⇒換算¥642,200 | 見積依頼/購入/質問フォーム |
Enterprise User(閲覧人数制限なし) | USD4,875 ⇒換算¥741,000 | 見積依頼/購入/質問フォーム |
※販売価格オプションの説明 ※お支払金額:換算金額(日本円)+消費税 ※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡) ※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能) |
当調査レポートは次の情報を含め、世界のメルカプトプリン経口液剤市場規模と予測を収録しています。・世界のメルカプトプリン経口液剤市場:売上、2018年-2023年、2024年-2029年 ・世界のメルカプトプリン経口液剤市場:販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のメルカプトプリン経口液剤市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「20mg/ml」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 メルカプトプリン経口液剤のグローバル主要企業は、Nova Laboratoriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL(MMG)は、メルカプトプリン経口液剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のメルカプトプリン経口液剤市場:タイプ別、2018年-2023年、2024年-2029年 世界のメルカプトプリン経口液剤市場:タイプ別市場シェア、2022年 ・20mg/ml、5mg/ml 世界のメルカプトプリン経口液剤市場:用途別、2018年-2023年、2024年-2029年 世界のメルカプトプリン経口液剤市場:用途別市場シェア、2022年 ・病院、薬局 世界のメルカプトプリン経口液剤市場:地域・国別、2018年-2023年、2024年-2029年 世界のメルカプトプリン経口液剤市場:地域別市場シェア、2022年 ・北米:アメリカ、カナダ、メキシコ ・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア ・アジア:中国、日本、韓国、東南アジア、インド ・南米:ブラジル、アルゼンチン ・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるメルカプトプリン経口液剤のグローバル売上、2018年-2023年 ・主要企業におけるメルカプトプリン経口液剤のグローバル売上シェア、2022年 ・主要企業におけるメルカプトプリン経口液剤のグローバル販売量、2018年-2023年 ・主要企業におけるメルカプトプリン経口液剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Nova Laboratories ************************************************************* ・調査・分析レポートの概要 メルカプトプリン経口液剤市場の定義 市場セグメント 世界のメルカプトプリン経口液剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のメルカプトプリン経口液剤市場規模 世界のメルカプトプリン経口液剤市場規模:2022年 VS 2029年 世界のメルカプトプリン経口液剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのメルカプトプリン経口液剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のメルカプトプリン経口液剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分:20mg/ml、5mg/ml メルカプトプリン経口液剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分:病院、薬局 メルカプトプリン経口液剤の用途別グローバル売上・予測 ・地域別市場分析 地域別メルカプトプリン経口液剤市場規模 2022年と2029年 地域別メルカプトプリン経口液剤売上・予測 北米市場:アメリカ、カナダ、メキシコ ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア アジア市場:中国、日本、韓国、東南アジア、インド 南米市場:ブラジル、アルゼンチン 中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど) Nova Laboratories ... |
Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine.
This report aims to provide a comprehensive presentation of the global market for Mercaptopurine Oral Solution Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mercaptopurine Oral Solution Drugs. This report contains market size and forecasts of Mercaptopurine Oral Solution Drugs in global, including the following market information:
Global Mercaptopurine Oral Solution Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Mercaptopurine Oral Solution Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Mercaptopurine Oral Solution Drugs companies in 2022 (%)
The global Mercaptopurine Oral Solution Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
20mg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mercaptopurine Oral Solution Drugs include Nova Laboratories. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mercaptopurine Oral Solution Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mercaptopurine Oral Solution Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mercaptopurine Oral Solution Drugs Market Segment Percentages, by Type, 2022 (%)
20mg/ml
5mg/ml
Global Mercaptopurine Oral Solution Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mercaptopurine Oral Solution Drugs Market Segment Percentages, by Application, 2022 (%)
Hosptial
Pharmacy
Global Mercaptopurine Oral Solution Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mercaptopurine Oral Solution Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mercaptopurine Oral Solution Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mercaptopurine Oral Solution Drugs revenues share in global market, 2022 (%)
Key companies Mercaptopurine Oral Solution Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Mercaptopurine Oral Solution Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nova Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mercaptopurine Oral Solution Drugs, market overview.
Chapter 2: Global Mercaptopurine Oral Solution Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Mercaptopurine Oral Solution Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mercaptopurine Oral Solution Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mercaptopurine Oral Solution Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
★調査レポート[世界のメルカプトプリン経口液剤市場予測2023-2029:20mg/ml、5mg/ml] (コード:MMG23JU5760)販売に関する免責事項を必ずご確認ください。 |
★調査レポート[世界のメルカプトプリン経口液剤市場予測2023-2029:20mg/ml、5mg/ml]についてメールでお問い合わせ |